Henry Schein (NASDAQ:HSIC) Announces Quarterly Earnings Results, Beats Estimates By $0.05 EPS

Henry Schein (NASDAQ:HSIC) announced its earnings results on Tuesday. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.17 by $0.05, Briefing.com reports. The firm had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The business’s quarterly revenue was up .4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.32 EPS. Henry Schein updated its FY 2024 guidance to 4.740-4.820 EPS.

Henry Schein Stock Up 1.5 %

HSIC stock opened at $70.01 on Thursday. The firm has a market capitalization of $8.87 billion, a PE ratio of 25.93, a P/E/G ratio of 2.08 and a beta of 0.87. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. Henry Schein has a twelve month low of $62.05 and a twelve month high of $82.63. The stock’s 50 day moving average is $70.59 and its 200-day moving average is $69.78.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. Robert W. Baird cut their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday. Evercore ISI increased their price target on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. One investment analyst has rated the stock with a sell rating, six have given a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Henry Schein has an average rating of “Hold” and an average target price of $77.50.

Insider Buying and Selling

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the transaction, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.14% of the stock is currently owned by corporate insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.